Ardena

A specialist CDMO and bioanalytical CRO supporting the development of complex, innovative medicines from early development through clinical and commercial stages, with integrated capabilities spanning drug product development, nanomedicine, ADCs and conjugation, bioanalytical services and CMC regulatory support. Ardena partners with biotech and pharma companies to advance small molecules, biologics and advanced therapies from sites across Europe and the US, including FDA-approved facilities.